EPIZYME, INC. Proceeds from Issuance Initial Public Offering
EPIZYME, INC. reported Proceeds from Issuance Initial Public Offering of $82.49 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2014-02-28
- EPIZYME, INC. proceeds from issuance initial public offering for the quarter ending 2013-12-31 was $0.00.
- EPIZYME, INC. proceeds from issuance initial public offering for the quarter ending 2013-09-30 was $0.00.
- EPIZYME, INC. proceeds from issuance initial public offering for fiscal 2013 was $82.49M.
| Period end | Proceeds from Issuance Initial Public Offering 0 month | Proceeds from Issuance Initial Public Offering 1 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $82.49M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $82.49M 10-Q · filed 2013-10-23 | ||||
| 2013-06-30 | $82.49M 10-Q · filed 2013-08-01 | |||||
| 2013-06-05 | $82.50M 10-K · filed 2014-02-28 | $82.50M 10-Q · filed 2013-10-23 |